Antitumor agents. Part 235: Novel 4'-ester etoposide analogues as potent DNA topoisomerase II inhibitors with improved therapeutic potential

Bioorg Med Chem. 2004 Jun 15;12(12):3363-9. doi: 10.1016/j.bmc.2004.03.056.

Abstract

Eight 4'-ester epipodophyllotoxin derivatives (9-16) were designed and synthesized with the aim to overcome drug-resistance and improve water-solubility simultaneously. These compounds were superior to etoposide (1) in causing cellular protein-linked DNA breaks and inhibiting KB and 1-resistant KB-7d cell replication. Compounds 9 and 10 showed significant inhibitory activity against DNA topoisomerase II in vitro. Compound 10 also exhibited an in vitro DNA cleavage pattern similar to that of GL-331 (5). A hypothetical model on the action mode of 1-analogues is proposed based on the results.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Antineoplastic Agents / chemical synthesis*
  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / pharmacology*
  • Antineoplastic Agents / therapeutic use
  • Binding Sites
  • Cell Division / drug effects
  • Cell Line, Tumor
  • DNA Topoisomerases, Type II / metabolism
  • Etoposide / analogs & derivatives*
  • Etoposide / chemical synthesis
  • Etoposide / chemistry
  • Etoposide / pharmacology*
  • Humans
  • Molecular Structure
  • Topoisomerase II Inhibitors*

Substances

  • 4'-ester etoposide
  • Antineoplastic Agents
  • Topoisomerase II Inhibitors
  • Etoposide
  • DNA Topoisomerases, Type II